Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 138

Published Date: 10 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor (GIST) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gastrointestinal Stromal Tumor (GIST) Drug industry chain, the market status of Clinic (Amcasertib, Anagrelide hydrochloride CR), Hospital (Amcasertib, Anagrelide hydrochloride CR), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Stromal Tumor (GIST) Drug.

Regionally, the report analyzes the Gastrointestinal Stromal Tumor (GIST) Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Stromal Tumor (GIST) Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gastrointestinal Stromal Tumor (GIST) Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Stromal Tumor (GIST) Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Amcasertib, Anagrelide hydrochloride CR).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Stromal Tumor (GIST) Drug market.

Regional Analysis: The report involves examining the Gastrointestinal Stromal Tumor (GIST) Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Stromal Tumor (GIST) Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gastrointestinal Stromal Tumor (GIST) Drug:
Company Analysis: Report covers individual Gastrointestinal Stromal Tumor (GIST) Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Stromal Tumor (GIST) Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinic, Hospital).

Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Stromal Tumor (GIST) Drug. It assesses the current state, advancements, and potential future developments in Gastrointestinal Stromal Tumor (GIST) Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Stromal Tumor (GIST) Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gastrointestinal Stromal Tumor (GIST) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others

Market segment by Application
Clinic
Hospital
Others

Major players covered
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor (GIST) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, with price, sales, revenue and global market share of Gastrointestinal Stromal Tumor (GIST) Drug from 2019 to 2024.
Chapter 3, the Gastrointestinal Stromal Tumor (GIST) Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Stromal Tumor (GIST) Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Gastrointestinal Stromal Tumor (GIST) Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumor (GIST) Drug.
Chapter 14 and 15, to describe Gastrointestinal Stromal Tumor (GIST) Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Amcasertib
        1.3.3 Anagrelide hydrochloride CR
        1.3.4 APG-1351
        1.3.5 Binimetinib
        1.3.6 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Clinic
        1.4.3 Hospital
        1.4.4 Others
    1.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size & Forecast
        1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (2019-2030)
        1.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Ariad Pharmaceuticals, Inc.
        2.1.1 Ariad Pharmaceuticals, Inc. Details
        2.1.2 Ariad Pharmaceuticals, Inc. Major Business
        2.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Ariad Pharmaceuticals, Inc. Recent Developments/Updates
    2.2 Arog Pharmaceuticals, Inc.
        2.2.1 Arog Pharmaceuticals, Inc. Details
        2.2.2 Arog Pharmaceuticals, Inc. Major Business
        2.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Arog Pharmaceuticals, Inc. Recent Developments/Updates
    2.3 Array BioPharma Inc.
        2.3.1 Array BioPharma Inc. Details
        2.3.2 Array BioPharma Inc. Major Business
        2.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Array BioPharma Inc. Recent Developments/Updates
    2.4 Astex Pharmaceuticals, Inc.
        2.4.1 Astex Pharmaceuticals, Inc. Details
        2.4.2 Astex Pharmaceuticals, Inc. Major Business
        2.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates
    2.5 Blueprint Medicines Corporation
        2.5.1 Blueprint Medicines Corporation Details
        2.5.2 Blueprint Medicines Corporation Major Business
        2.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Blueprint Medicines Corporation Recent Developments/Updates
    2.6 Boston Biomedical, Inc.
        2.6.1 Boston Biomedical, Inc. Details
        2.6.2 Boston Biomedical, Inc. Major Business
        2.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Boston Biomedical, Inc. Recent Developments/Updates
    2.7 Calithera Biosciences, Inc.
        2.7.1 Calithera Biosciences, Inc. Details
        2.7.2 Calithera Biosciences, Inc. Major Business
        2.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Calithera Biosciences, Inc. Recent Developments/Updates
    2.8 Chipscreen Biosciences Ltd
        2.8.1 Chipscreen Biosciences Ltd Details
        2.8.2 Chipscreen Biosciences Ltd Major Business
        2.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Chipscreen Biosciences Ltd Recent Developments/Updates
    2.9 Deciphera Pharmaceuticals, LLC
        2.9.1 Deciphera Pharmaceuticals, LLC Details
        2.9.2 Deciphera Pharmaceuticals, LLC Major Business
        2.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Deciphera Pharmaceuticals, LLC Recent Developments/Updates
    2.10 F. Hoffmann-La Roche Ltd.
        2.10.1 F. Hoffmann-La Roche Ltd. Details
        2.10.2 F. Hoffmann-La Roche Ltd. Major Business
        2.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
    2.11 Horizon Pharma Plc
        2.11.1 Horizon Pharma Plc Details
        2.11.2 Horizon Pharma Plc Major Business
        2.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Horizon Pharma Plc Recent Developments/Updates
    2.12 Immunicum AB
        2.12.1 Immunicum AB Details
        2.12.2 Immunicum AB Major Business
        2.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Immunicum AB Recent Developments/Updates
    2.13 Jiangsu Hengrui Medicine Co., Ltd.
        2.13.1 Jiangsu Hengrui Medicine Co., Ltd. Details
        2.13.2 Jiangsu Hengrui Medicine Co., Ltd. Major Business
        2.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
    2.14 Kolltan Pharmaceuticals, Inc.
        2.14.1 Kolltan Pharmaceuticals, Inc. Details
        2.14.2 Kolltan Pharmaceuticals, Inc. Major Business
        2.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
    2.15 Natco Pharma Limited
        2.15.1 Natco Pharma Limited Details
        2.15.2 Natco Pharma Limited Major Business
        2.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Natco Pharma Limited Recent Developments/Updates
    2.16 Nerviano Medical Sciences S.r.l.
        2.16.1 Nerviano Medical Sciences S.r.l. Details
        2.16.2 Nerviano Medical Sciences S.r.l. Major Business
        2.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Nerviano Medical Sciences S.r.l. Recent Developments/Updates
    2.17 Novartis AG
        2.17.1 Novartis AG Details
        2.17.2 Novartis AG Major Business
        2.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Novartis AG Recent Developments/Updates
    2.18 Omeros Corporation
        2.18.1 Omeros Corporation Details
        2.18.2 Omeros Corporation Major Business
        2.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
        2.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Omeros Corporation Recent Developments/Updates

3 Competitive Environment: Gastrointestinal Stromal Tumor (GIST) Drug by Manufacturer
    3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2019-2024)
    3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Gastrointestinal Stromal Tumor (GIST) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share in 2023
        3.4.2 Top 6 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share in 2023
    3.5 Gastrointestinal Stromal Tumor (GIST) Drug Market: Overall Company Footprint Analysis
        3.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market: Region Footprint
        3.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Type Footprint
        3.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
        4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2019-2030)
        4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2019-2030)
        4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Region (2019-2030)
    4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030)
    4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030)
    4.4 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030)
    4.5 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030)
    4.6 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2030)
    5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Type (2019-2030)
    5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2030)
    6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Application (2019-2030)
    6.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2019-2030)

7 North America
    7.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2030)
    7.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2030)
    7.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        7.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2030)
        7.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2030)
    8.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2030)
    8.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        8.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2030)
        8.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
        9.3.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2030)
    10.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2030)
    10.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        10.3.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2030)
        10.3.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
        11.3.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
    12.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
    12.3 Gastrointestinal Stromal Tumor (GIST) Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Gastrointestinal Stromal Tumor (GIST) Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Gastrointestinal Stromal Tumor (GIST) Drug
    13.3 Gastrointestinal Stromal Tumor (GIST) Drug Production Process
    13.4 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Gastrointestinal Stromal Tumor (GIST) Drug Typical Distributors
    14.3 Gastrointestinal Stromal Tumor (GIST) Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Ariad Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 4. Ariad Pharmaceuticals, Inc. Major Business
    Table 5. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 6. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Ariad Pharmaceuticals, Inc. Recent Developments/Updates
    Table 8. Arog Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 9. Arog Pharmaceuticals, Inc. Major Business
    Table 10. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 11. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Arog Pharmaceuticals, Inc. Recent Developments/Updates
    Table 13. Array BioPharma Inc. Basic Information, Manufacturing Base and Competitors
    Table 14. Array BioPharma Inc. Major Business
    Table 15. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 16. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Array BioPharma Inc. Recent Developments/Updates
    Table 18. Astex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 19. Astex Pharmaceuticals, Inc. Major Business
    Table 20. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 21. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Astex Pharmaceuticals, Inc. Recent Developments/Updates
    Table 23. Blueprint Medicines Corporation Basic Information, Manufacturing Base and Competitors
    Table 24. Blueprint Medicines Corporation Major Business
    Table 25. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 26. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Blueprint Medicines Corporation Recent Developments/Updates
    Table 28. Boston Biomedical, Inc. Basic Information, Manufacturing Base and Competitors
    Table 29. Boston Biomedical, Inc. Major Business
    Table 30. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 31. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Boston Biomedical, Inc. Recent Developments/Updates
    Table 33. Calithera Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
    Table 34. Calithera Biosciences, Inc. Major Business
    Table 35. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 36. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Calithera Biosciences, Inc. Recent Developments/Updates
    Table 38. Chipscreen Biosciences Ltd Basic Information, Manufacturing Base and Competitors
    Table 39. Chipscreen Biosciences Ltd Major Business
    Table 40. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 41. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Chipscreen Biosciences Ltd Recent Developments/Updates
    Table 43. Deciphera Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
    Table 44. Deciphera Pharmaceuticals, LLC Major Business
    Table 45. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 46. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Deciphera Pharmaceuticals, LLC Recent Developments/Updates
    Table 48. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
    Table 49. F. Hoffmann-La Roche Ltd. Major Business
    Table 50. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 51. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
    Table 53. Horizon Pharma Plc Basic Information, Manufacturing Base and Competitors
    Table 54. Horizon Pharma Plc Major Business
    Table 55. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 56. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Horizon Pharma Plc Recent Developments/Updates
    Table 58. Immunicum AB Basic Information, Manufacturing Base and Competitors
    Table 59. Immunicum AB Major Business
    Table 60. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 61. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Immunicum AB Recent Developments/Updates
    Table 63. Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 64. Jiangsu Hengrui Medicine Co., Ltd. Major Business
    Table 65. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 66. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
    Table 68. Kolltan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
    Table 69. Kolltan Pharmaceuticals, Inc. Major Business
    Table 70. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 71. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. Kolltan Pharmaceuticals, Inc. Recent Developments/Updates
    Table 73. Natco Pharma Limited Basic Information, Manufacturing Base and Competitors
    Table 74. Natco Pharma Limited Major Business
    Table 75. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 76. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Natco Pharma Limited Recent Developments/Updates
    Table 78. Nerviano Medical Sciences S.r.l. Basic Information, Manufacturing Base and Competitors
    Table 79. Nerviano Medical Sciences S.r.l. Major Business
    Table 80. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 81. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 82. Nerviano Medical Sciences S.r.l. Recent Developments/Updates
    Table 83. Novartis AG Basic Information, Manufacturing Base and Competitors
    Table 84. Novartis AG Major Business
    Table 85. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 86. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 87. Novartis AG Recent Developments/Updates
    Table 88. Omeros Corporation Basic Information, Manufacturing Base and Competitors
    Table 89. Omeros Corporation Major Business
    Table 90. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
    Table 91. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 92. Omeros Corporation Recent Developments/Updates
    Table 93. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
    Table 94. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 95. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
    Table 96. Market Position of Manufacturers in Gastrointestinal Stromal Tumor (GIST) Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 97. Head Office and Gastrointestinal Stromal Tumor (GIST) Drug Production Site of Key Manufacturer
    Table 98. Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Type Footprint
    Table 99. Gastrointestinal Stromal Tumor (GIST) Drug Market: Company Product Application Footprint
    Table 100. Gastrointestinal Stromal Tumor (GIST) Drug New Market Entrants and Barriers to Market Entry
    Table 101. Gastrointestinal Stromal Tumor (GIST) Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 102. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 103. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 104. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 105. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 106. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Region (2019-2024) & (USD/Pcs)
    Table 107. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Region (2025-2030) & (USD/Pcs)
    Table 108. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 109. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 110. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 111. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 112. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2019-2024) & (USD/Pcs)
    Table 113. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2025-2030) & (USD/Pcs)
    Table 114. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 115. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 116. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 117. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 118. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2019-2024) & (USD/Pcs)
    Table 119. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2025-2030) & (USD/Pcs)
    Table 120. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 121. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 122. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 123. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 124. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 125. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 126. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 127. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 128. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 129. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 130. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 131. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 132. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 133. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 134. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 135. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 136. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 137. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 138. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 139. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 140. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 141. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 142. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 143. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 144. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 145. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 146. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 147. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 148. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 149. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 150. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 151. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 152. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 153. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 154. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 155. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 156. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 157. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 158. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 159. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 160. Gastrointestinal Stromal Tumor (GIST) Drug Raw Material
    Table 161. Key Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug Raw Materials
    Table 162. Gastrointestinal Stromal Tumor (GIST) Drug Typical Distributors
    Table 163. Gastrointestinal Stromal Tumor (GIST) Drug Typical Customers
List of Figures
    Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Picture
    Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Type in 2023
    Figure 4. Amcasertib Examples
    Figure 5. Anagrelide hydrochloride CR Examples
    Figure 6. APG-1351 Examples
    Figure 7. Binimetinib Examples
    Figure 8. Others Examples
    Figure 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Application in 2023
    Figure 11. Clinic Examples
    Figure 12. Hospital Examples
    Figure 13. Others Examples
    Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity (2019-2030) & (K Pcs)
    Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (2019-2030) & (USD/Pcs)
    Figure 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Manufacturer in 2023
    Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Manufacturer in 2023
    Figure 20. Producer Shipments of Gastrointestinal Stromal Tumor (GIST) Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 21. Top 3 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Top 6 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 25. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 26. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 27. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 28. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 29. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Type (2019-2030) & (USD/Pcs)
    Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Application (2019-2030) & (USD/Pcs)
    Figure 36. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 37. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 39. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 40. United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 44. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 45. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 46. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 47. Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. France Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. United Kingdom Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 53. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 54. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 55. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 56. China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. India Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 63. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 64. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 65. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 66. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 68. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 69. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 70. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 71. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 72. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
    Figure 77. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
    Figure 78. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in 2023
    Figure 81. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
    Figure 82. Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation

Related Reports

Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Gastrointestinal Stromal Tumor (GIST) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 16 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor (GIST) Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Gastrointestinal Stromal Tumor (GIST) Drug Supply, Demand and Key Producers, 2023-2029

Global Gastrointestinal Stromal Tumor (GIST) Drug Supply, Demand and Key Producers, 2023-2029

date 07 Feb 2023

date Pharma & Healthcare

This report studies the global Gastrointestinal Stromal Tumor (GIST) Drug production, demand, key manufacturers, and key regions.

Product Tags

Gastrointestinal Stromal Tumor (GIST) Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>